Faculty profile

Paola Marcato

ResearcherPathologyDalhousie University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Dalhousie University directory, so their courses may be missing. Find their university profile.

Paola Marcato

Researcher

Pathology

Health Sciences

Dalhousie University

Halifax, Nova Scotia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
17 publications in the last five years, latest in 2026.
Senior (last) author on 14 recent papers, a sign of leading a research group.
Principal investigator on 6 research grants (6 CIHR), most recently in 2023.
Supervised 5 trainees who won CIHR awards, most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

109

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Breast Cancer Gene Expression Long Non-Coding Rna Aldh1a3 Metastasis Cancer Progression Molecular Mechanisms Novel Targets

Latest papers

LINC01929 mediates breast cancer immunosuppression and is an immunotherapy target.
iScience · 2026 · senior author
Peptide-mediated immunomodulation of tumor microenvironment in triple-negative breast cancer: A comprehensive review.
The Journal of pharmacology and experimental therapeutics · 2026
Selective inhibition of ALDH1A3 impedes breast cancer growth and metastasis by blocking ALDH1A3-driven transcriptional programs.
iScience · 2026 · senior author

All 62 publications

Latest funding

Investigating mechanisms of NRAD1 in breast cancer progression
CIHR · 2025 · Supervisor
$120,000
Assessing the pharmacological mechanisms of jadomycins in triple-negative breast cancer
CIHR · 2025 · Co-investigator
$1,055,700
Investigating targeting aldehyde dehydrogenase 1A3 in the treatment of cancer
CIHR · 2024 · Supervisor
$120,000

All 13 grants and awards

62 publications.

LINC01929 mediates breast cancer immunosuppression and is an immunotherapy target.

Venkatesh J, Wasson MD, Arun RP, Cahill HF, Walker OL, Dean CA, Fernando W, MacLean MR, McLean ME, Khan B, Kruth PS, Sultonova M, Nersesian S, Lee SN, Longjohn MN, Hughes CS, Belbin TJ, Gaston D, Paulo JA, Knapp GC, Bethune G, Gujar S, Boudreau JE, Murphy JP, Marcato P

iScience2026Senior author

DOI: 10.1016/j.isci.2026.115381 PMID: 41993692

Peptide-mediated immunomodulation of tumor microenvironment in triple-negative breast cancer: A comprehensive review.

Bhayo AM, Marcato P, Ahmed M

The Journal of pharmacology and experimental therapeutics2026

DOI: 10.1016/j.jpet.2026.104324 PMID: 42019163

Selective inhibition of ALDH1A3 impedes breast cancer growth and metastasis by blocking ALDH1A3-driven transcriptional programs.

MacLean MR, Bernardoni BL, Fernando W, Petrarolo G, D'Agostino I, Dean CA, Venkatesh J, Hughes CS, Goralski KB, Subramanian G, Arun RP, Cahill HF, Walker OL, Thomas LN, Douglas RC, La Motta C, Marcato P

iScience2026Senior author

DOI: 10.1016/j.isci.2026.114863 PMID: 41797928

Expression of carcinoma ecotypes in the tumor microenvironment predicts response to neoadjuvant therapy in early-stage breast cancer.

Asleh K, Bethune G, Marcato P

Scientific reports2025Senior author

DOI: 10.1038/s41598-025-28810-z PMID: 41286068

THSD4 is a novel mediator of T cell exclusion and anti-PD-1 resistance in hormone receptor-positive breast cancer.

Walker OL, Wasson MD, Kumar V, Nersesian S, Venkatesh J, Vijayan VV, Coates L, Fernando W, Arun RP, Cahill HF, Baker E, Dahn ML, Slauenwhite D, Cruickshank BM, Barnes P, Longjohn MN, Belbin TJ, Gaston D, Knapp GC, Melvin J, Gujar S, Boudreau JE, Bethune G, Marcato P

Biomarker research2025Senior author

DOI: 10.1186/s40364-025-00850-7 PMID: 41153058

LncRNA NRAD1 regulates the triple-negative breast cancer transcriptome by miRNA biogenesis, localization, and predominately non-ceRNA interactions.

Cahill HF, Brown JM, Leslie-Toogood M, Venkatesh J, Wasson MD, Arun RP, McLean ME, Vidovic D, Marcato P

Scientific reports2025Senior author

DOI: 10.1038/s41598-025-12415-7 PMID: 40696096

ALDH1A3 is the switch that determines the balance of ALDH+ and CD24-CD44+ cancer stem cells, EMT-MET, and glucose metabolism in breast cancer.

Fernando W, Cruickshank BM, Arun RP, MacLean MR, Cahill HF, Morales-Quintanilla F, Dean CA, Wasson MD, Dahn ML, Coyle KM, Walker OL, Power Coombs MR, Marcato P

Oncogene2024Senior author

DOI: 10.1038/s41388-024-03156-4 PMID: 39251846

Phloridzin Docosahexaenoate, an Omega-3 Fatty Acid Ester of a Flavonoid Precursor, Inhibits Angiogenesis by Suppressing Endothelial Cell Proliferation, Migration, and Differentiation.

Fernando W, MacLean E, Monro S, Power Coombs MR, Marcato P, Rupasinghe HPV, Hoskin DW

Biomolecules2024

DOI: 10.3390/biom14070769 PMID: 39062483

Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways.

MacLean MR, Walker OL, Arun RP, Fernando W, Marcato P

International journal of molecular sciences2024Senior author

DOI: 10.3390/ijms25074102 PMID: 38612911

LncRNAs exhibit subtype-specific expression, survival associations, and cancer-promoting effects in breast cancer.

Wasson MD, Venkatesh J, Cahill HF, McLean ME, Dean CA, Marcato P

Gene2024Senior author

DOI: 10.1016/j.gene.2024.148165 PMID: 38219875

Something wrong or missing on this profile? Suggest a correction

Paola Marcato

Research

Latest papers

Latest funding

LINC01929 mediates breast cancer immunosuppression and is an immunotherapy target.

Peptide-mediated immunomodulation of tumor microenvironment in triple-negative breast cancer: A comprehensive review.

Selective inhibition of ALDH1A3 impedes breast cancer growth and metastasis by blocking ALDH1A3-driven transcriptional programs.

Expression of carcinoma ecotypes in the tumor microenvironment predicts response to neoadjuvant therapy in early-stage breast cancer.

THSD4 is a novel mediator of T cell exclusion and anti-PD-1 resistance in hormone receptor-positive breast cancer.

LncRNA NRAD1 regulates the triple-negative breast cancer transcriptome by miRNA biogenesis, localization, and predominately non-ceRNA interactions.

ALDH1A3 is the switch that determines the balance of ALDH+ and CD24-CD44+ cancer stem cells, EMT-MET, and glucose metabolism in breast cancer.

Phloridzin Docosahexaenoate, an Omega-3 Fatty Acid Ester of a Flavonoid Precursor, Inhibits Angiogenesis by Suppressing Endothelial Cell Proliferation, Migration, and Differentiation.

Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways.

LncRNAs exhibit subtype-specific expression, survival associations, and cancer-promoting effects in breast cancer.

Investigating mechanisms of NRAD1 in breast cancer progression

Assessing the pharmacological mechanisms of jadomycins in triple-negative breast cancer

Investigating targeting aldehyde dehydrogenase 1A3 in the treatment of cancer

Cystine/glutamate antiporter system xc- as a target for HER2-positive breast cancer treatment

Investigating the role of LINC01929 in regulating processes critical for breast cancer progression

Targeting ALDH1A3 and investigating mechanisms of ALDH1A3-mediated breast cancer progression

Identification of lncRNAs that regulate biological processes required for breast cancer progression

Pan-cancer genomic profiling identifies novel breast cancer targets among long non-coding RNA

Defining the mechanism of ALDH1A3 in breast cancer for the identification of novel therapeutic targets

Identification of Novel Hypermethylated Tumor Suppressor Genes Important in Breast Cancer Progression and Treatment Response

Frequent collaborators

Shashi Gujar

Roy Duncan

Sherri Mcfarland

Graham Dellaire

Sheila Singh

Giovanni Blandino

Roseline Godbout